Karyopharm Therapeutics(DE:25K0)
€0.020.00 (0.00%)
DE:25K0
Karyopharm Therapeutics earnings date
€0.02
At close:0.00 (0.00%)
Karyopharm Therapeutics (25K0) Q2 2024 Earnings Report
1 Followers
DE:25K0 Q2 2024 EPS Results
- Actual EPS
- -EUR 2.69
- Consensus EPS
- -EUR 4.01
- Beat/Miss
- Beat by +EUR 1.32
- One Year Ago EPS
- -EUR 3.90
DE:25K0 Q2 2024 Revenue Results
- Actual Revenue
- EUR 38.37M
- Expected Revenue
- EUR 32.47M
- Beat/Miss
- Beat by +EUR 5.90M
- YoY Revenue Growth
- +13.86%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/06/2024
- Time
- Before Open
- Conference Call
- Tuesday, August 6, 2024
DE:25K0 Upcoming Earnings
Karyopharm Therapeutics's next earnings date is estimated for February 10, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
DE:25K0 Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:25K0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 10, 2027 | 2026 (Q4) | ―- | -5.12 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | -0.30- | -3.43 | ― | |
| Aug 13, 2026 | 2026 (Q2) | -1.23-2.08 | -3.87 | 46.30% (+1.79) | |
| May 14, 2026 | 2026 (Q1) | -1.27-1.11 | -2.48 | 55.23% (+1.37) | |
| Feb 12, 2026 | 2025 (Q4) | -1.79-5.12 | -3.23 | -58.61% (-1.89) | |
| Nov 03, 2025 | 2025 (Q3) | -3.11-3.43 | -3.5 | 2.05% (+0.07) | |
| Aug 11, 2025 | 2025 (Q2) | -3.66-3.87 | -2.69 | -44.00% (-1.18) | |
| May 12, 2025 | 2025 (Q1) | -3.96-2.48 | -4.3 | 42.29% (+1.82) | |
| Feb 19, 2025 | 2024 (Q4) | -3.52-3.23 | -4.84 | 33.33% (+1.61) | |
| Nov 05, 2024 | 2024 (Q3) | -3.54-3.50 | -4.04 | 13.33% (+0.54) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


